Parecoxib Sodium

ๅธ•็‘žๆ˜”ๅธƒ้’ 

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameParecoxib Sodium
Drug Alias Nameๅธ•็‘ž่€ƒๆ˜”Parecoxibumๅธ•็‘ž่€ƒๆ˜”้’ ๅธ•็ซ‹ๆ˜”ๅธƒๅธ•็‘ž่ฅฟๅœ +[11]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsPain, PostoperativeNervous System DiseasesShoulder Pain
Global Approved IndicationsPain, Postoperative
Approved Indications in ChinaPain, Postoperative
Original Approved Country/TerritoryEU
Original Approved Date2002/03/22
Country/TerritoryCzechiaThailandEU +[4]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active IndicationsPain, PostoperativeNervous System Diseases
Inactive IndicationsShoulder Pain

Other Information

ATC CodeM01AH04